JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
出版年份 2014 全文链接
标题
JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
作者
关键词
-
出版物
Cell Death & Disease
Volume 5, Issue 12, Pages e1551-e1551
出版商
Springer Nature
发表日期
2014-12-05
DOI
10.1038/cddis.2014.517
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inositol Pyrophosphates Mediate the DNA-PK/ATM-p53 Cell Death Pathway by Regulating CK2 Phosphorylation of Tti1/Tel2
- (2014) Feng Rao et al. MOLECULAR CELL
- TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer
- (2014) W Xu et al. Cell Death & Disease
- JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma
- (2013) Jing Lu et al. CARCINOGENESIS
- JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer
- (2013) Yansu Chen et al. CARCINOGENESIS
- XPD-dependent activation of apoptosis in response to triplex-induced DNA damage
- (2013) Meetu Kaushik Tiwari et al. NUCLEIC ACIDS RESEARCH
- Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair
- (2013) C Barckhausen et al. ONCOGENE
- Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer
- (2012) S. Wang et al. CLINICAL CANCER RESEARCH
- Clinicopathological and functional significance of XRCC1 expression in ovarian cancer
- (2012) Tarek Abdel-Fatah et al. INTERNATIONAL JOURNAL OF CANCER
- Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance
- (2012) Qingshan Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
- (2012) Yung-Jue Bang et al. LANCET
- CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy
- (2012) A. Siddiqui-Jain et al. MOLECULAR CANCER THERAPEUTICS
- Plk1 and CK2 Act in Concert to Regulate Rad51 during DNA Double Strand Break Repair
- (2012) Keiko Yata et al. MOLECULAR CELL
- Integrated epigenomic analysis sheds light on role of BMP4 in regulating cisplatin sensitivity in gastric cancer
- (2012) Natalie J. Wood Nature Reviews Gastroenterology & Hepatology
- Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1 and inhibition of platinum–DNA adduct repair
- (2012) K Kudo et al. ONCOGENE
- Subcellular targets of cisplatin cytotoxicity: An integrated view
- (2012) Sandra M. Sancho-Martínez et al. PHARMACOLOGY & THERAPEUTICS
- JWA enhances As2O3-induced tubulin polymerization and apoptosis via p38 in HeLa and MCF-7 cells
- (2011) Lianlian Shen et al. APOPTOSIS
- CK2 phosphorylation of XRCC1 facilitates dissociation from DNA and single-strand break formation during base excision repair
- (2011) Cecilia E. Ström et al. DNA REPAIR
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- DNA Damage and Repair in Translational Oncology: An Overview
- (2010) E. Reed CLINICAL CANCER RESEARCH
- XRCC1 phosphorylation by CK2 is required for its stability and efficient DNA repair
- (2010) Jason L. Parsons et al. DNA REPAIR
- Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
- (2010) Svetlana Usanova et al. Molecular Cancer
- FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
- (2010) J. M.-M. Kwok et al. MOLECULAR CANCER RESEARCH
- Photoaffinity Labeling Reveals Nuclear Proteins That Uniquely Recognize Cisplatin−DNA Interstrand Cross-Links
- (2009) Guangyu Zhu et al. BIOCHEMISTRY
- Protein Kinase CK2 in Health and Disease
- (2009) L. A. Pinna et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- JWA Sensitizes P-Glycoprotein-Mediated Drug-Resistant Choriocarcinoma Cells to Etoposide VIA JNK and Mitochondrial-Associated Signal Pathway
- (2009) Yan Zhang et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
- JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative-stress-induced DNA single-strand breaks
- (2009) Shouyu Wang et al. NUCLEIC ACIDS RESEARCH
- JWA regulates melanoma metastasis by integrin αVβ3 signaling
- (2009) J Bai et al. ONCOGENE
- Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms
- (2009) Rong Zhang et al. TOXICOLOGY LETTERS
- JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway
- (2008) Jinhong Zhou et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started